Maintenance treatment of asthma in adults inadequately controlled w/ maintenance combination of long-acting β
2-agonist & high dose of inhaled corticosteroid & who experienced ≥1 asthma exacerbations in the previous yr. 100/6/12.5 mcg: Maintenance treatment in adult patients w/ moderate to severe COPD who are inadequately treated by combination of long-acting β
2-agonist w/ inhaled corticosteroid or long-acting muscarinic antagonist.